Multifunctional Block Copolymer Micelles for the Delivery of 111In to EGFR-Positive Breast Cancer Cells for Targeted Auger Electron Radiotherapy

被引:21
作者
Fonge, Humphrey
Lee, Helen
Reilly, Raymond M. [2 ,3 ]
Allen, Christine [1 ,4 ,5 ]
机构
[1] Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada
[2] Univ Toronto, Dept Med Imaging, Toronto, ON M5S 3M2, Canada
[3] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada
[4] Univ Toronto, Dept Chem, Toronto, ON M5S 3M2, Canada
[5] Univ Hlth Network, Princess Margaret Hosp, Radiat Med Program, STTARR Innovat Ctr, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Epidermal growth factor receptor; Auger electron radiotherapy; breast cancer; block copolymer micelle; In-111; EPIDERMAL-GROWTH-FACTOR; TUMOR VASCULAR-PERMEABILITY; FACTOR RECEPTOR; DRUG-DELIVERY; IN-VIVO; CELLULAR INTERNALIZATION; NANOPARTICLE FORMULATION; PHASE-I; THERAPY; DOXORUBICIN;
D O I
10.1021/mp900201v
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Block copolymer micelles (BCMs) can improve the payload delivery of therapeutic agents to tumors. Our aim was to construct hEGF-modified BCMs for the delivery of In-111 to tumor cells for Auger electron-emission radiotherapy of EGFR-positive breast cancer (BC). Multifunctional nanosized BCMs were prepared from MePEG(2500)-b-PCL1200 and In-111-DTPA-PEG(3000)-b-PCL1600 with or without hEGF-PEG(2900)-b-PCL1400 (In-111-hEGF-BCMs or In-111-BCMs). The resulting BCMs were analyzed by dynamic light scattering and transmission electron microscopy. Cellular uptake and nuclear importation were assessed in MDA-MB-468, MDA-MB-231 and MCF-7 BC cells with decreasing EGFR density. In vitro antiproliferative effects were evaluated using the WST-1 assay after 48 h with In-111-hEGF-BCMs, and the clonogenic assay was used to determine the survival fraction (SF) after a 21 h exposure. Results were compared with In-111-DTPA-hEGF, an established Auger electron-emitting radiotherapeutic that is currently in clinical development. Cell uptake and nuclear importation of In-111-hEGF-BCMs decreased in the following order: MDA-MB-468 > MDA-MB-231 > MCF-7. Cellular uptake of In-111-hEGF-BCMs was less than In-111-DTPA-hEGF (P < 0.05) but was 4-fold higher than for In-111-BCMs (P < 0.001). There was a significant growth inhibition of MDA-MB-468 cells by In-111-hEGF-BCMs (6-fold inhibition, P < 0.05) while the growth of MDA-MB-231 and MCF-7 were not significantly inhibited. The SF of MDA-MB-468 cells was decreased to 2.6% while that for MCF-7 cells was 132.7%. In-111-DTPA-hEGF reduced the SF of MDA-MB-468 cells to 0.4%. Nontargeted In-111-BCMs had minimal effect on the SF of BC cells. Therefore, the In-111-hEGF-BCMs were bound, internalized and transported to the nuclei of EGFR-positive BC cells, where the Auger electron emissions were lethal. The In-111-hEGF-BCMs are a promising delivery system for targeted radiotherapy of BC.
引用
收藏
页码:177 / 186
页数:10
相关论文
共 50 条
[21]   Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer [J].
Hu, MD ;
Chen, P ;
Wang, J ;
Chan, C ;
Scollard, DA ;
Reilly, RM .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (03) :301-310
[22]  
JAIN RK, 1987, CANCER RES, V47, P3039
[23]   Doxorubicin-loaded poly(ethylene glycol)-poly(β-benzyl-l-aspartate) copolymer micelles:: their pharmaceutical characteristics and biological significance [J].
Kataoka, K ;
Matsumoto, T ;
Yokoyama, M ;
Okano, T ;
Sakurai, Y ;
Fukushima, S ;
Okamoto, K ;
Kwon, GS .
JOURNAL OF CONTROLLED RELEASE, 2000, 64 (1-3) :143-153
[24]   THE CLINICAL-SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR (EGF-R) IN HUMAN BREAST-CANCER - A REVIEW ON 5232 PATIENTS [J].
KLIJN, JGM ;
BERNS, PMJJ ;
SCHMITZ, PIM ;
FOEKENS, JA .
ENDOCRINE REVIEWS, 1992, 13 (01) :3-17
[25]   Apoptotic epidermal growth factor (EGF)-Conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapy [J].
Lee, Helen ;
Hu, Meiduo ;
Reilly, Raymond M. ;
Allen, Christine .
MOLECULAR PHARMACEUTICS, 2007, 4 (05) :769-781
[26]   Formulation of drugs in block copolymer micelles: Drug loading and release [J].
Liu, J. ;
Lee, H. ;
Allen, C. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (36) :4685-4701
[27]   Cellular internalization of poly(ethylene oxide)-b-poly(ε-caprolactone) diblock copolymer micelles [J].
Luo, LB ;
Tam, J ;
Maysinger, D ;
Eisenberg, A .
BIOCONJUGATE CHEMISTRY, 2002, 13 (06) :1259-1265
[28]   Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS [J].
Maeda, H ;
Sawa, T ;
Konno, T .
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) :47-61
[29]   Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review [J].
Maeda, H ;
Wu, J ;
Sawa, T ;
Matsumura, Y ;
Hori, K .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :271-284
[30]   Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo [J].
Mamot, C ;
Drummond, DC ;
Noble, CO ;
Kallab, V ;
Guo, ZX ;
Hong, KL ;
Kirpotin, DB ;
Park, JW .
CANCER RESEARCH, 2005, 65 (24) :11631-11638